UPDATE 1-US FDA warns St. Jude on heart device claims
* Claims for two heart devices draw objections
* Company says working to address FDA concerns
WASHINGTON May 18 (Reuters) - Device maker St Jude Medical Inc (STJ.N) made improper claims about two heart devices, U.S. regulators said in a letter to the company.
The Food and Drug Administration, in an April 23 letter, objected to statements made on a company website about the Epicor LP Cardiac Ablation System and the Epicor UltraCinch LP Ablation Device.
St. Jude spokeswoman Marisa Bluestone said the company is "working diligently to address the points raised in the warning letter and to resolve the FDA's concerns."
- Exclusive: Iran seeks give and take on Islamic State militants, nuclear program
- Alibaba IPO ranks as world's biggest after additional shares sold
- Islamic State tells followers to attack U.S., French citizens: website
- Study of smoking cancer patients fuels e-cigarette debate
- Kurds say they have halted Islamic State advance on Syrian town |